Cart is empty
View Cart
Subtotal: $0.00
JOIN NOW!
Featured Image

Devens’ BMS Integrates New Capabilities in an Existing Plant & Wins ISPE Facility Integration Award

  • Posted by jwillard
  • On February 16, 2017
The Bristol-Myers Squibb (BMS) campus at Devens is part of the company’s Global Manufacturing Network. The two newest facilities, the Biologics Development Building (BDB) and the Clinical Manufacturing Building (CMB), recently earned BMS the ISPE Facility of the Year (FOYA) Facility Integration Award. The new facilities were designed and built in an efficient manner and […]
Read More
 

Amgen’s Humira Biosimilar Moves Forward in Europe Amid Patent Fight with Abbvie

  • Posted by jwillard
  • On February 6, 2017
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the Marketing of ABP 501, a biosimilar for Abbvie’s Humira (adalimumab). The committee recommended approval for all available indications, including moderate-to-severe rheumatoid arthritis, chronic plaque psoriasis, Crohn’s disease and ulcerative colitis. ABP 501 is the first Humira […]
Read More